Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
In a significant development for the pulmonary fibrosis market, Boehringer Ingelheim’s investigational therapy, nerandomilast, demonstrated a statistically significant reduction in the rate of Forced Vital Capacity (FVC) decline among patients ... Read More
Continuous Coverage
Austria’s corporate insolvency rate surged 28% year-over-year in Q1 2026, with 72% of failures driven by unsustainable cost…
Donald Trump’s recent remarks regarding potential military action against Iran have injected a fresh layer of volatility into…
The Senegalese government’s payroll just hit a staggering milestone: 125.2 billion CFA francs in January 2026—enough to buy…
Authorities in Ontario and Saskatchewan are investigating the death of a missing少年 following the recovery of his remains,…
Fluminense faces a pivotal Libertadores showdown against Bolívar this evening at the Maracanã. With the squad list finalized,…
When a Dutch reality TV star’s violent outburst sparks nationwide outrage, the fallout reveals the volatile intersection of…
Global Affairs
Cuba’s President Miguel Díaz-Canel warned this week that a U.S. Military strike would trigger a “bloodbath with incalculable…
Markets And Money
Intuitive Machines (NASDAQ:IM) misses Q1 2026 EPS guidance, triggering mixed market reactions. The space tech firm reported a…
Digital Culture
Sony has quietly dropped a premium variant of its flagship WH-1000XM6 noise-canceling headphones—now rebranded as the WH-1000XM6 The…
Science And Wellbeing
Recent research underscores the importance of dietary protein variety, balancing health benefits and risks across sources like legumes,…
Screen And Sound
Trey Parker and Matt Stone’s *South Park* Season 29 returns in September 2026, with 14 new episodes airing…
Fixtures And Form
Athena’s 2026 ROH Women’s World Championship reign—now at 218 days—has eclipsed Roman Reigns’ 216-day WWE Universal Title run,…
